Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem J 346(Pt 1):155-161

Department of Biochemistry, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, U.K.
Biochemical Journal (Impact Factor: 4.78). 03/2000; 346 Pt 1(1):155-61. DOI: 10.1042/0264-6021:3460155
Source: PubMed

ABSTRACT Proteasomes can exist in several different molecular forms in mammalian cells. The core 20S proteasome, containing the proteolytic sites, binds regulatory complexes at the ends of its cylindrical structure. Together with two 19S ATPase regulatory complexes it forms the 26S proteasome, which is involved in ubiquitin-dependent proteolysis. The 20S proteasome can also bind 11S regulatory complexes (REG, PA28) which play a role in antigen processing, as do the three variable gamma-interferon-inducible catalytic beta-subunits (e.g. LMP7). In the present study, we have investigated the subcellular distribution of the different forms of proteasomes using subunit specific antibodies. Both 20S proteasomes and their 19S regulatory complexes are found in nuclear, cytosolic and microsomal preparations isolated from rat liver. LMP7 was enriched approximately two-fold compared with core alpha-type proteasome subunits in the microsomal preparations. 20S proteasomes were more abundant than 26S proteasomes, both in liver and cultured cell lines. Interestingly, some significant differences were observed in the distribution of different subunits of the 19S regulatory complexes. S12, and to a lesser extent p45, were found to be relatively enriched in nuclear fractions from rat liver, and immunofluorescent labelling of cultured cells with anti-p45 antibodies showed stronger labelling in the nucleus than in the cytoplasm. The REG was found to be localized predominantly in the cytoplasm. Three- to six-fold increases in the level of REG were observed following gamma-interferon treatment of cultured cells but gamma-interferon had no obvious effect on its subcellular distribution. These results demonstrate that different regulatory complexes and subpopulations of proteasomes have different distributions within mammalian cells and, therefore, that the distribution is more complex than has been reported for yeast proteasomes.

Download full-text


Available from: Rachael Zoe Murray, Jul 03, 2014
  • Source
    • "It is also noteworthy that the cylinder-shaped 20S catalytic core of the 26S proteasome can dissociate from the larger complex and is itself catalytically active, degrading proteins in the absence of ATP and ubiquitin. In fact, the 20S proteasome is the predominant enzyme form in most mammalian cells [64] and rather selectively degrades oxidized, misfolded and covalently modified proteins [65] [66]. Such degradation is critical as a means of cellular detoxification, as damaged proteins are potentially harmful because they can become entangled into protein aggregates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this review, we describe research findings on the effects of alcohol exposure on two major catabolic systems in liver cells: the ubiquitin–proteasome system (UPS) and autophagy. These hydrolytic systems are not unique to liver cells; they exist in all eukaryotic tissues and cells. However, because the liver is the principal site of ethanol metabolism, it sustains the greatest damage from heavy drinking. Thus, the focus of this review is to specifically describe how ethanol oxidation modulates the activities of the UPS and autophagy and the mechanisms by which these changes contribute to the pathogenesis of alcohol-induced liver injury. Here, we describe the history and the importance of cellular hydrolytic systems, followed by a description of each catabolic pathway and the differential modulation of each by ethanol exposure. Overall, the evidence for an involvement of these catabolic systems in the pathogenesis of alcoholic liver disease is quite strong. It underscores their importance, not only as effective means of cellular recycling and eventual energy generation, but also as essential components of cellular defense.
    12/2014; 3. DOI:10.1016/j.redox.2014.10.006
  • Source
    • "Examples include pergerin, a component of the MOZ/MORF complex, which has a transcription regulation role (Ullah et al., 2008); endothelial differentiation-related factor 1, which is another transcription regulator that can be involved in cell differentiation (Dragoni et al., 1998); and cystatin-B, which is a reversible inhibitor of cathepsins L, H, and B. Moreover, proteasome activator complex subunit 3, a subunit of the 11S REG-gamma proteosome regulator, resides in the cytoplasm during mitosis following nuclear envelope breakdown (Brooks et al., 2000). Proteins residing at cytoplasm/plasma membrane site are the second most abundant in the class (10%) followed by those at cytoplasm/ cytoskeleton (8%). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The clinical application of human bone marrow stromal cells (hBMSCs) largely depends on their capacity to expand in vitro. We have conducted a comprehensive comparative proteomic analysis of culture-expanded hBMSCs obtained from different human donors. The data reveal extensive donor-to-donor proteomic heterogeneity. Processing and database-searching of the tandem MS data resulted in a most comprehensive to date proteomic dataset for hBMSC. A total of 7753 proteins including 712 transcription and translation regulators, 384 kinases, 248 receptor proteins, and 29 cytokines were confidently identified. The proteins identified are mainly nuclear (43.2%) and the share of proteins assigned to more than one subcellular location constitutes 10% of the identified proteome. Bioinformatics tools (IPA, DAVID, and PANTHER) were used to annotate proteins with respect to cellular locations, functions, and other physicochemical characteristics. We also compared the proteomic profile of hBMSCs to recently compiled datasets for human and mouse pluripotent stem cells. The result shows the extent of similarity between the three cell populations and also identified 253 proteins expressed uniformly by all lines of hBMSCs but not reported in the proteomic datasets of the two pluripotent stem cells. Overall, the proteomic database reported in this paper can serve as a reference map for extensive evaluation of hBMSC to explain their biology as well as identify possible marker candidates for further evaluation.
    Stem Cell Research 06/2013; 11(2):793-805. DOI:10.1016/j.scr.2013.05.006 · 3.91 Impact Factor
  • Source
    • "Many cytoplasmic proteases also exist in the cell [57], and the most prominent one is the proteasome. The 26S proteasome is a large (~2.5 MDa) multicatalytic protease that is primarily cytoplasmic , although a significant proteasome population exists in the nucleus and—intriguingly—is associated with the ER membrane [58] [59]. Indiscriminant proteolysis is prevented by the preferential selection of polyubiquitinated substrates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: All newly synthesized proteins are subject to quality control check-points, which prevent aberrant polypeptides from harming the cell. For proteins that ultimately reside in the cytoplasm, components that also reside in the cytoplasm were known for many years to mediate quality control. Early biochemical and genetic data indicated that misfolded proteins were selected by molecular chaperones and then targeted to the proteasome (in eukaryotes) or to proteasome-like particles (in bacteria) for degradation. What was less clear was how secreted and integral membrane proteins, which in eukaryotes enter the endoplasmic reticulum (ER), were subject to quality control decisions. In this review, we highlight early studies that ultimately led to the discovery that secreted and integral membrane proteins also utilize several components that constitute the cytoplasmic quality machinery. This component of the cellular quality control pathway is known as ER associated degradation, or ERAD.
    Biochimica et Biophysica Acta 04/2013; 1833(11). DOI:10.1016/j.bbamcr.2013.03.018 · 4.66 Impact Factor
Show more